Aktas B - Search Results

1

Comparison of ¹⁸F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix.

Sarabhai T, Schaarschmidt BM, Wetter A, Kirchner J, Aktas B, Forsting M, Ruhlmann V, Herrmann K, Umutlu L, Grueneisen J. Sarabhai T, et al. Among authors: aktas b. Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):67-76. doi: 10.1007/s00259-017-3809-y. Epub 2017 Aug 24. Eur J Nucl Med Mol Imaging. 2018. PMID: 28840302

2

Definition of compartment-based radical surgery in uterine cancer: radical hysterectomy in cervical cancer as 'total mesometrial resection (TMMR)' by M Höckel translated to robotic surgery (rTMMR).

Kimmig R, Wimberger P, Buderath P, Aktas B, Iannaccone A, Heubner M. Kimmig R, et al. Among authors: aktas b. World J Surg Oncol. 2013 Aug 26;11:211. doi: 10.1186/1477-7819-11-211. World J Surg Oncol. 2013. PMID: 23972128 Free PMC article.

3

Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET/MRI of primary and recurrent cervical cancer.

Grueneisen J, Beiderwellen K, Heusch P, Buderath P, Aktas B, Gratz M, Forsting M, Lauenstein T, Ruhlmann V, Umutlu L. Grueneisen J, et al. Among authors: aktas b. PLoS One. 2014 May 7;9(5):e96751. doi: 10.1371/journal.pone.0096751. eCollection 2014. PLoS One. 2014. PMID: 24804676 Free PMC article.

4

[(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results.

Beiderwellen K, Grueneisen J, Ruhlmann V, Buderath P, Aktas B, Heusch P, Kraff O, Forsting M, Lauenstein TC, Umutlu L. Beiderwellen K, et al. Among authors: aktas b. Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):56-65. doi: 10.1007/s00259-014-2902-8. Epub 2014 Sep 16. Eur J Nucl Med Mol Imaging. 2015. PMID: 25223420

5

Integrated PET/MRI for whole-body staging of patients with primary cervical cancer: preliminary results.

Grueneisen J, Schaarschmidt BM, Heubner M, Aktas B, Kinner S, Forsting M, Lauenstein T, Ruhlmann V, Umutlu L. Grueneisen J, et al. Among authors: aktas b. Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1814-24. doi: 10.1007/s00259-015-3131-5. Epub 2015 Jul 22. Eur J Nucl Med Mol Imaging. 2015. PMID: 26199113 Clinical Trial.

6

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT.

Kirchner J, Sawicki LM, Suntharalingam S, Grueneisen J, Ruhlmann V, Aktas B, Deuschl C, Herrmann K, Antoch G, Forsting M, Umutlu L. Kirchner J, et al. Among authors: aktas b. PLoS One. 2017 Feb 22;12(2):e0172553. doi: 10.1371/journal.pone.0172553. eCollection 2017. PLoS One. 2017. PMID: 28225831 Free PMC article.

7

Evaluation of PET and MR datasets in integrated 18F-FDG PET/MRI: A comparison of different MR sequences for whole-body restaging of breast cancer patients.

Grueneisen J, Sawicki LM, Wetter A, Kirchner J, Kinner S, Aktas B, Forsting M, Ruhlmann V, Umutlu L. Grueneisen J, et al. Among authors: aktas b. Eur J Radiol. 2017 Apr;89:14-19. doi: 10.1016/j.ejrad.2016.12.019. Epub 2017 Jan 22. Eur J Radiol. 2017. PMID: 28267530

8

Comparison of ¹⁸F-FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study.

Sawicki LM, Kirchner J, Grueneisen J, Ruhlmann V, Aktas B, Schaarschmidt BM, Forsting M, Herrmann K, Antoch G, Umutlu L. Sawicki LM, et al. Among authors: aktas b. Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):622-629. doi: 10.1007/s00259-017-3881-3. Epub 2017 Nov 21. Eur J Nucl Med Mol Imaging. 2018. PMID: 29164299

9

Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials.

Graeser M, Schrading S, Gluz O, Strobel K, Herzog C, Umutlu L, Frydrychowicz A, Rjosk-Dendorfer D, Würstlein R, Culemann R, Eulenburg C, Adams J, Nitzsche H, Prange A, Kümmel S, Grischke EM, Forstbauer H, Braun M, Potenberg J, von Schumann R, Aktas B, Kolberg-Liedtke C, Harbeck N, Kuhl CK, Nitz U. Graeser M, et al. Among authors: aktas b. Breast Cancer Res. 2021 Mar 18;23(1):36. doi: 10.1186/s13058-021-01413-y. Breast Cancer Res. 2021. PMID: 33736679 Free PMC article.

10

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.

Aktas B, Müller V, Tewes M, Zeitz J, Kasimir-Bauer S, Loehberg CR, Rack B, Schneeweiss A, Fehm T. Aktas B, et al. Gynecol Oncol. 2011 Aug;122(2):356-60. doi: 10.1016/j.ygyno.2011.04.039. Epub 2011 May 24. Gynecol Oncol. 2011. PMID: 21605893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

402 results

Search Page

Filters